In these tumor conditions, GD3 has been reported to contribute not only to the promotion of tumor cells, but to the suppression of antitumor immunity by inhibiting the functional activities of dendritic cells and CD4 T cells (11–15). The gene discussed is CD4; the disease is neoplasm.